Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma?

Kocsis, A ✉ [Kocsis, Ádám László (plasztikai sebészet), author] Department of Dermatology and Allergology (USZ / ASZMS); Karsko, L; Kurgyis, Zs [Kurgyis, Zsuzsanna (bőrgyógyászat), author] Department of Dermatology and Allergology (USZ / ASZMS); Besenyi, Zs [Besenyi, Zsuzsanna (nukleáris medicina), author] Department of Nuclear Medicine (USZ / ASZMS); Pavics, L [Pávics, László (nukleáris medicin...), author] Department of Nuclear Medicine (USZ / ASZMS); Dosa-Racz, E [Viharosné Dósa-Rácz, Éva (biostatisztika), author] Department of Dermatology and Allergology (USZ / ASZMS); Kis, E [Kis, Erika (plasztikai sebészet), author] Department of Dermatology and Allergology (USZ / ASZMS); Baltas, E [Baltás, Eszter (Bőrgyógyászat, kl...), author] Department of Dermatology and Allergology (USZ / ASZMS); Ocsai, H [Ócsai, Henriette (Bőrgyógyászat, kl...), author] Department of Dermatology and Allergology (USZ / ASZMS); Varga, E [Varga, Erika (dermatologia, der...), author] Department of Dermatology and Allergology (USZ / ASZMS); Bende, B [Bende, Balázs (Sebészet), author] Department of Dermatology and Allergology (USZ / ASZMS); Varga, A [Varga, Ákos (plasztikai és égé...), author] Department of Dermatology and Allergology (USZ / ASZMS); Mohos, G [Mohos, Gábor (Plasztikai sebészet), author] Department of Dermatology and Allergology (USZ / ASZMS); Korom, I [Korom, Irma (bőrgyógyászati pa...), author] Department of Dermatology and Allergology (USZ / ASZMS); Varga, J [Varga, János (plasztikai sebészet), author] Department of Dermatology and Allergology (USZ / ASZMS); Kemeny, L [Kemény, Lajos (Bőrgyógyászat, im...), author] Department of Dermatology and Allergology (USZ / ASZMS); Nemeth, I B ✉ [Németh, István Balázs (pathologia, bőrgy...), author] Department of Dermatology and Allergology (USZ / ASZMS); Olah, J [Oláh, Judit Magdolna (Bőrgyógyászat, On...), author] Department of Dermatology and Allergology (USZ / ASZMS); Department of Oncotherapy (USZ / ASZMS)

English Scientific Article (Journal Article)
  • SJR Scopus - Medicine (miscellaneous): Q2
Identifiers
Subjects:
    Sentinel lymph node biopsy (SLNB) is a standard procedure for regional lymph node staging and still has the most important prognostic value for the outcome of patients with thin melanoma. In addition to ulceration, SLNB had to be considered even for a single mitotic figure in thin (<1 mm) melanoma according to AJCC7th guideline, therefore, a retrospective review was conducted involving 403 pT1 melanoma patients. Among them, 152 patients suffered from pT1b ulcerated or mitotic rate ≥ 1/ mm2 melanomas according to the AJCC7th staging system. SLNB was performed in 78 cases, of which nine (11.5%) showed SLN positivity. From them, interestingly, we found a relatively high positive sentinel rate (6/78-8%) in the case of thin primary melanomas ˂0.8 mm. Moreover, the presence of regression increased the probability of sentinel positivity by 5.796 fold. After reassessing pT stage based on the new AJCC8th, 37 pT1b cases were reordered into pT1a category. There was no significant relation between other characteristics examined (age, gender, Breslow, Clark level, and mitosis index) and sentinel node positivity. Based on our data, we suggest that mitotic rate alone is not a sufficiently powerful predictor of SLN status in thin melanomas. If strict histopathological definition criteria are applied, regression might be an additional adverse feature that aids in identifying T1 patients most likely to be SLN-positive. After reassessing of pT1b cases according to AJCC8th regression proved to be independent prognostic factor on sentinel lymph node positivity. Our results propose that sentinel lymph node biopsy might also be considered at patients with regressive thin (˂0.8 mm) melanomas.
    Citation styles: IEEEACMAPAChicagoHarvardCSLCopyPrint
    2021-09-23 08:18